Last Updated:
Name Designation Appointment Date Status
Jurg Reto Roth

Appointed as Director since January 2018

Director 15-Jan-2018 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Geistlich Pharma India Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Matthias Peter Hermann Dunkel

Appointed as Director since October 2020

Director 26-Oct-2020 Current
Prakash Virendra Kotak

Appointed as Director since November 2015

Director 28-Nov-2015 Current
Martin Rudolf Wartmann

Appointed as Director since September 2025

Director 19-Sep-2025 Current

People Timeline

Explore the timeline of key personnel in Geistlich Pharma India Private Limited's leadership journey.

Loading...
Contact Details
  • Address Unit No. Dsm 162 On 1St Floor, Dlf Tower, Shivaji Marg,, New Delhi Delhi, 110015, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Geistlich Pharma India Private Limited through their registered address at Unit No. Dsm 162 On 1St Floor, Dlf Tower, Shivaji Marg,, New Delhi Delhi, 110015, India, or via their website at geistlich.in. Social media links are also provided where applicable.
The current directors of Geistlich Pharma India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • MATTHIAS PETER HERMANN DUNKEL
  • JURG RETO ROTH
  • PRAKASH VIRENDRA KOTAK
  • Martin Rudolf Wartmann
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available